Clin2
NCT06716970Possibly a fitNot yet recruiting

New combination pill for high blood pressure

Essential Hypertension

Treatments studied

Part of Heart & circulation clinical trials.

This study tests a new pill that combines two blood pressure medicines to see if it can lower blood pressure more effectively in people with moderate to severe high blood pressure. If you have high blood pressure that is not well controlled, this trial might help you find a new treatment option.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
810 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • Your body mass index (BMI) is 30 or less.
  • You have moderate to severe high blood pressure, either untreated or currently on medication.
  • You are willing to use effective birth control during the study and for one month after.
  • You do not have certain other health conditions like heart disease, stroke, or cancer within the last few years.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06643819Recruiting· Phase 3
Testing a new blood pressure drug

This trial tests a new combination blood pressure medicine called CKD-202A. It is for adults with high blood pressure who have not had other treatments or conditions that could affect the results.

Wŏnju
NCT07373613Not yet recruiting· Phase 2
Blood pressure study for people with high blood pressure

This study tests five new medicines to see if they can lower blood pressure in people with mild to moderate essential hypertension. It may help you if your blood pressure is not well controlled and you are willing to take the study medicine for a period of time.

Soeul
NCT06441630Recruiting· Phase 3
Testing two new high blood pressure medicines together

This trial tests a combination of two new medications (AD-227A and AD-227B) to see if they work better together for people with essential (common) high blood pressure. It could be a new treatment option to help control your blood pressure.

Seoul
NCT07152444Not yet recruiting· Phase 1
Testing a new drug for mild high blood pressure

This early-stage study tests a new investigational drug called QLS1410 in healthy adults and people with mild high blood pressure. The goal is to see how the drug works and if it is safe.

Beijing
NCT07654140Recruiting· Phase 2
Testing a new drug for uncontrolled high blood pressure

This trial tests a new drug called SAL0140 for people whose high blood pressure is not controlled by current treatments. It may help lower blood pressure when other medications haven't worked well enough.

Beijing, Beijing Municipality
NCT07241338Not yet recruiting· Phase 4
Blood pressure and weight control in people with overweight

This study tests whether a medication can help control blood pressure and support weight management in people with overweight and high blood pressure. It may offer a new option for improving heart health.

Beijing

Hear when a new Essential Hypertension trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.